ATE456955T1 - Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen - Google Patents
Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungenInfo
- Publication number
- ATE456955T1 ATE456955T1 AT05801277T AT05801277T ATE456955T1 AT E456955 T1 ATE456955 T1 AT E456955T1 AT 05801277 T AT05801277 T AT 05801277T AT 05801277 T AT05801277 T AT 05801277T AT E456955 T1 ATE456955 T1 AT E456955T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclodextrin
- treat
- inflammatory disease
- bronchial inflammatory
- prevent bronchial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104957A EP1655034A1 (de) | 2004-10-10 | 2004-10-10 | Verwendung von Cyclodextrin zur Behandlung und Vorbeugung von entzündlichen Bronchialerkrankungen. |
| PCT/EP2005/054966 WO2006037769A1 (en) | 2004-10-10 | 2005-09-30 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE456955T1 true ATE456955T1 (de) | 2010-02-15 |
Family
ID=34929683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05801277T ATE456955T1 (de) | 2004-10-10 | 2005-09-30 | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7829550B2 (de) |
| EP (2) | EP1655034A1 (de) |
| JP (1) | JP4989481B2 (de) |
| AT (1) | ATE456955T1 (de) |
| DE (1) | DE602005019247D1 (de) |
| ES (1) | ES2340511T3 (de) |
| PL (1) | PL1799231T3 (de) |
| WO (1) | WO2006037769A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9545424B2 (en) | 2007-06-01 | 2017-01-17 | SolAero Med Inc. | Method of treating pulmonary surfactant dysfunction or respiratory distress syndrome by administering cyclodextrin or a derivative thereof |
| EP2600864B1 (de) * | 2010-08-04 | 2019-01-09 | University Of Virginia Patent Foundation | Zusammensetzungen und verfahren zur behandlung von entzündungskrankheiten |
| CA2880880C (en) | 2012-08-03 | 2021-01-26 | John Mckew | Cyclodextrin for the treatment of lysosomal storage diseases |
| RU2506080C1 (ru) * | 2012-09-25 | 2014-02-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО НижГМА Минздравсоцразвития России) | Способ лечения и профилактики осложнений в полости рта, вызванных приемом ингаляционных гормональных препаратов у больных бронхиальной астмой |
| WO2014047715A1 (en) * | 2012-09-27 | 2014-04-03 | Solaeromed Inc. | Treatment of pulmonary surfactant dysfunction using cholesterol-sequestering cyclodextrins |
| FR3014694B1 (fr) | 2013-12-13 | 2016-11-11 | Roquette Freres | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| CN106413759B (zh) * | 2014-03-28 | 2022-02-22 | 列日大学 | 用于治疗和预防肺部炎症的包含环糊精和布地奈德衍生物的组合物 |
| EP2923702A1 (de) * | 2014-03-28 | 2015-09-30 | Universite De Liege | Zusammensetzung von Cyclodextrin mit Budesonidderivaten zur Behandlung und Vorbeugung von entzündlichen Lungenerkrankungen |
| KR20180035787A (ko) * | 2015-06-10 | 2018-04-06 | 브이테스, 인코포레이티드 | 히드록시프로필 베타-시클로덱스트린 조성물 및 방법 |
| FR3083234B1 (fr) * | 2018-06-29 | 2020-11-27 | Roquette Freres | Nouvelles hydroxypropyl-beta-cyclodextrines et leurs procedes de preparation |
| WO2020002851A1 (fr) * | 2018-06-29 | 2020-01-02 | Roquette Freres | NOUVELLE HYDROXYPROPYL-β-CYCLODEXTRINE ET SON PROCÉDÉ DE PRÉPARATION |
| BE1027425B1 (fr) | 2019-07-01 | 2021-02-08 | Aquilon Pharmaceuticals | Composition inhalable comprenant de la cyclodextrine a utiliser dans le traitement d’inflammations nasales |
| BE1027612B1 (fr) | 2019-09-10 | 2021-05-03 | Aquilon Pharmaceuticals | Microparticules en forme de balle de golf pour une utilisation dans le traitement et la prevention de maladies pulmonaires |
| US11045434B1 (en) | 2020-04-01 | 2021-06-29 | UNION therapeutics A/S | Niclosamide formulations for treating disease |
| MA53516A1 (fr) * | 2020-06-15 | 2022-04-29 | Univ Liege | Cyclodextrine utilisée dans le traitement et la prévention de la bronchoconstriction en phase tardive de l'asthme provoqué par des allergènes. |
| BE1030002B1 (fr) | 2021-12-29 | 2023-09-01 | Aquilon Pharmaceuticals | Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire |
| WO2023118014A1 (en) | 2021-12-20 | 2023-06-29 | Aquilon Pharmaceuticals | Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease |
| US11958917B2 (en) | 2022-02-18 | 2024-04-16 | Beren Therapeutics P.B.C. | Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4054736A (en) * | 1970-06-10 | 1977-10-18 | Ono Pharmaceutical Co., Ltd. | Clathrate compounds of prostaglandins or their analogues with cyclodextrin |
| JPS62123132A (ja) * | 1985-11-21 | 1987-06-04 | Michio Nakanishi | 気管支喘息治療用組成物 |
| JPS62292719A (ja) * | 1986-06-12 | 1987-12-19 | Kaken Pharmaceut Co Ltd | 外用澄明水溶性製剤 |
| US5254541A (en) * | 1991-11-15 | 1993-10-19 | Merck Frosst Canada, Inc. | (Quinolin-2-ylmethoxy)indole/cyclodextrin complex |
| US5840713A (en) * | 1995-04-03 | 1998-11-24 | Weisz; Paul B. | Therapy for tissue membrane insufficiency |
| JP2001503406A (ja) * | 1996-10-28 | 2001-03-13 | ファーマーク、ニーダーランド、ベスローテン、フェンノートシャップ | 医薬組成物 |
| JP2006008568A (ja) * | 2004-06-24 | 2006-01-12 | Cyclochem:Kk | ＩｇＥ抗体抑制剤および食品 |
-
2004
- 2004-10-10 EP EP04104957A patent/EP1655034A1/de not_active Withdrawn
-
2005
- 2005-09-30 PL PL05801277T patent/PL1799231T3/pl unknown
- 2005-09-30 US US11/664,999 patent/US7829550B2/en active Active
- 2005-09-30 ES ES05801277T patent/ES2340511T3/es active Active
- 2005-09-30 DE DE602005019247T patent/DE602005019247D1/de active Active
- 2005-09-30 JP JP2007535148A patent/JP4989481B2/ja active Active
- 2005-09-30 AT AT05801277T patent/ATE456955T1/de active
- 2005-09-30 WO PCT/EP2005/054966 patent/WO2006037769A1/en active Application Filing
- 2005-09-30 EP EP05801277A patent/EP1799231B1/de active Active
-
2010
- 2010-07-29 US US12/846,241 patent/US20110028432A1/en not_active Abandoned
-
2012
- 2012-05-23 US US13/478,743 patent/US20120295872A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1655034A1 (de) | 2006-05-10 |
| EP1799231B1 (de) | 2010-02-03 |
| US20110028432A1 (en) | 2011-02-03 |
| US20090012041A1 (en) | 2009-01-08 |
| WO2006037769A1 (en) | 2006-04-13 |
| EP1799231A1 (de) | 2007-06-27 |
| US20120295872A1 (en) | 2012-11-22 |
| US7829550B2 (en) | 2010-11-09 |
| JP2008515847A (ja) | 2008-05-15 |
| ES2340511T3 (es) | 2010-06-04 |
| JP4989481B2 (ja) | 2012-08-01 |
| PL1799231T3 (pl) | 2010-07-30 |
| DE602005019247D1 (de) | 2010-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE456955T1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
| CY1111437T1 (el) | Τετραϋδροπυρρολοπυριμιδινοδιονες και η χρηση τους ως αναστολεων της ανθρωπινης ουδετεροφιλης ελαστασης | |
| ATE412414T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen | |
| ATE519488T1 (de) | Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
| ATE534391T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen | |
| DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
| DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
| ATE446754T1 (de) | Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten | |
| ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| DE502005007427D1 (de) | 3-aminoindazole derivate und ihre verwendung zur behandlung sgk-bedingten krankheiten | |
| DE602004022871D1 (de) | Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten | |
| ATE375977T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
| ATE390925T1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| DE602005017636D1 (de) | Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen | |
| DE602005014145D1 (de) | Medikamente zur behandlung oder prävention fibrotischer krankheiten | |
| DE602005014141D1 (de) | Medikamente zur behandlung oder prävention fibrotischer krankheiten | |
| EA200801244A1 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
| DE602005015697D1 (de) | Te zur behandlung von alzheimer-krankheit | |
| CY1114760T1 (el) | Θεραπευτικη αγωγη αθηροσκληρωσης | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| ATE457727T1 (de) | Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen | |
| DE602005015434D1 (de) | Mittel zur behandlung von psychoneurotischen krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1799231 Country of ref document: EP |